GI & Endoscopy

Here are 10 updates on GI companies from the past week.

Gainesville, Va.-based Gastroenterology Associates partnered with Elligo Health Research to provide clinical research services to patients.

Owings Mills, Md.-based Chesapeake Urology partnered with HIFU Prostate Services to provide non-invasive HIFU treatments for prostate cancer.

Using patient-derived three-dimensional 'organoid' models may help personalize therapy for people with GI cancers, according to a BJS review.

David Scholz, MD, is a gastroenterologist at Charlotte (N.C.) Gastroenterology & Hepatology.

Fecal immunochemical testing is a noninvasive alternative to colonoscopy, but researchers at three U.S.-based universities are examining how effective the testing really is.

Pharmaceutical companies Pierre Fabre and Array BioPharma conducted a phase III trial evaluating a triple combination therapy for metastatic colorectal cancer patients, Labiotech reports.

With the release of the ASC Quality Reporting data for 2018, CMS allows users to search the average number of GI procedures performed per ASC by state.

Nebraska medical startup Virtual Incision Corp. completed an $18 million series B round of financing, Silicon Prairie News reports. Virtual Incision developed a surgical robot for colon resection, and the funds will go to manufacturing and clinical trials leading to…

CellMax Life published results from a study showing its circulating tumor cell blood test accurately detected colorectal cancer and precancerous lesions at an 87 percent and 77 percent accuracy rate, respectively.